| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |